相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inside the pathophysiological mechanisms of cardiometabolic diseases: the other pandemic to fight
Marcelo R. Choi
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2022)
Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development
Noheul Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
ANTIDIABETIC AND HEPATOPROTECTIVE ACTIVITIES OF BOMBAX CEIBA EXTRACT IN OBESE RATS WITH METABOLIC SYNDROME
Omnia Aly et al.
PLANT ARCHIVES (2021)
Retinol-binding protein 4 in obesity and metabolic dysfunctions
Pamela A. Nono Nankam et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models: molecular targets
Zaida Zakaria et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2021)
RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women
Murat Kilicarslan et al.
FASEB JOURNAL (2020)
Recent advances in the development of sesquiterpenoids in the treatment of type 2 diabetes
Lei Chen et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2019)
Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening
Andreia S. P. Pereira et al.
MOLECULES (2019)
Human plasma retinol-binding protein (RBP4) is also a fatty acid-binding protein
Massimiliano Perduca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease
Raghdaa Hamdan Al Zarzour et al.
NUTRIENTS (2018)
Resveratrol: A Double-Edged Sword in Health Benefits
Bahare Salehi et al.
BIOMEDICINES (2018)
Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Zhongwei Zhou et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial
Xia Sun et al.
METABOLIC BRAIN DISEASE (2017)
A comprehensive review of the health perspectives of resveratrol
Abdur Rauf et al.
FOOD & FUNCTION (2017)
Aptamer-Conjugated Calcium Phosphate Nanoparticles for Reducing Diabetes Risk via Retinol Binding Protein 4 Inhibition
Raheleh Torabi et al.
CANADIAN JOURNAL OF DIABETES (2017)
Effects of phenolic-rich extracts of Clinacanthus nutans on high fat and high cholesterol diet-induced insulin resistance
Nadarajan Sarega et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
The Possible Role of Flavonoids in the Prevention of Diabetic Complications
Roberto Testa et al.
NUTRIENTS (2016)
Pioglitazone Lowers Serum Retinol Binding Protein 4 by Suppressing its Expression in Adipose Tissue of Obese Rats
Chaoyu Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Antidiabetic properties of dietary flavonoids: a cellular mechanism review
Ramachandran Vinayagam et al.
NUTRITION & METABOLISM (2015)
Application of Berberine on Treating Type 2 Diabetes Mellitus
Bing Pang et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Retinol Binding Protein 4 in Relation to Diet, Inflammation, Immunity, and Cardiovascular Diseases
Fateme Zabetian-Targhi et al.
ADVANCES IN NUTRITION (2015)
Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4
Yingcai Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
RBP4 Activates Antigen-Presenting Cells, Leading to Adipose Tissue Inflammation and Systemic Insulin Resistance
Pedro M. Moraes-Vieira et al.
CELL METABOLISM (2014)
Long-term Drug Treatment for Obesity A Systematic and Clinical Review
Susan Z. Yanovski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease
Christopher L. Cioffi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Plasma Retinol-Binding Protein 4 (RBP4) Levels and Risk of Coronary Heart Disease A Prospective Analysis Among Women in the Nurses' Health Study
Qi Sun et al.
CIRCULATION (2013)
INVESTIGATION OF ORAL FENRETINIDE FOR TREATMENT OF GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION
Nathan L. Mata et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
A1120, a Nonretinoid RBP4 Antagonist, Inhibits Formation of Cytotoxic Bisretinoids in the Animal Model of Enhanced Retinal Lipofuscinogenesis
Nicoleta Dobri et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review
Suzanne J. Grant et al.
BMC PUBLIC HEALTH (2012)
Natural Products: A safest Approach for Obesity
Neeru Vasudeva et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2012)
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Stephen S. Lim et al.
LANCET (2012)
Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats
Francesca Delucchi et al.
PLOS ONE (2012)
Resveratrol enhances fatty acid oxidation capacity and reduces resistin and Retinol-Binding Protein 4 expression in white adipocytes
Josep Mercader et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Selective peroxisome proliferator-activated receptor gamma (PPAR gamma) modulation as a strategy for safer therapeutic PPAR gamma activation
Linda Slanec Higgins et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Discovery and Development of Therapeutic Aptamers
P. R. Bouchard et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo
Alykhan Motani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hepatoxicity associated with weight-loss supplements: A case for better post-marketing surveillance
Ano Lobb
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Fenretinide corrects newly found ceramide deficiency in cystic fibrosis
Claudine Guilbault et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
A Target Based Therapeutic Approach Towards Diabetes Mellitus Using Medicinal Plants
Pranav K. Prabhakar et al.
CURRENT DIABETES REVIEWS (2008)
Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone
Aiwei Yao-Borengasser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans
Norbert Stefan et al.
DIABETES CARE (2007)
Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation
Prabhakaran Balagopal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients
D. G. Haider et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Synthetic retinoid fenretinide in breast cancer chemoprevention
Bernardo Bonanni et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties:: a review
G. Bagalkotkar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
Young Min Cho et al.
DIABETES CARE (2006)
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
U. Veronesi et al.
ANNALS OF ONCOLOGY (2006)
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
Timothy E. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Clinical trials with retinoids for breast cancer chemoprevention
S Zanardi et al.
ENDOCRINE-RELATED CANCER (2006)
Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: A potential therapy for treatment of lipofuscin-based retinal diseases
RA Radu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells
MH Pan et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
分享论文
